Cargando…

Allogeneic natural killer cell therapy

Interest in adoptive cell therapy for treating cancer is exploding owing to early clinical successes of autologous chimeric antigen receptor (CAR) T lymphocyte therapy. However, limitations using T cells and autologous cell products are apparent as they (1) take weeks to generate, (2) utilize a 1:1...

Descripción completa

Detalles Bibliográficos
Autores principales: Berrien-Elliott, Melissa M., Jacobs, Miriam T., Fehniger, Todd A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10023727/
https://www.ncbi.nlm.nih.gov/pubmed/36416736
http://dx.doi.org/10.1182/blood.2022016200